Research Studies

Current Clinical Trials:

Study: Injectable Treatment to Treat Cutaneous Squamous Cell Carcinoma

Purpose: The purpose of this trial is to evaluate the safety, tolerability, and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma in situskin cancer(isSCC).

Qualifications:

• Male and Females, 18 years or older
• Current diagnosis of SCC

Duration: Up to 14 weeks

Location: Hackensack, NJ

Compensation: Up to $785

Interested in participating in our clinical research study? Please click here.

---

Study: Injectable Treatment to Treat Keloids

Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.

Qualifications:

• Male and Females, 18 – 60 years old
• Have at least one keloid scar present for at least one year on the upper body, arms, or legs

Duration: 54 weeks

Location: Hackensack, NJ

Compensation: Up to $1,100 if all study visits are completed

To participate Please click here.

---

Study: Alopecia Areata

Purpose: The primary objective of the study is to assess the effects of dose reduction or drug discontinuation subsequent to hair regrowth following 24 weeks of treatment with either 8 mg BID or 12 mg BID of CTP-543 in adult patients with moderate to severe alopecia areata.

Qualifications:

• Male and Females, ages 18 to 65 inclusive
• Definitive diagnosis of alopecia areata with a current episode of scalp hair loss lasting at least 6 months and not exceeding 10 years at the time of Screening. Total disease duration greater than 10 years is permitted.
• At least 50% scalp hair loss, as defined by a SALT score ≥50, at Screening and Baseline.

Duration: Approx. 52 weeks

Location: Hackensack, NJ

Compensation: $50 per visit will be paid to patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Prurigo Nodularis

Purpose: To evaluate the effect of NAL ER (oral tablet) on itch as assessed by the percentage of Responders (‘response’ is defined as a ≥ 4-point reduction in the 7-day average Worst Itch – Numerical Rating Scale [WI-NRS]).

Qualifications:

• Male and Females, 18 years or older
• Must have PN on 2 areas of the body

Duration: Up to 56 weeks

Location: Hackensack, NJ

Compensation: $100 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Vitiligo Trial

Purpose: Vitiligo is a skin condition in which there is a loss of color (referred to as “depigmentation”) from areas of skin. This results in uneven white patches that have no pigment, but the skin feels like normal. The purpose of the study you are being asked to participate in is to evaluate the safety and effectiveness of the RECELL® Device when used for repigmentation of stable vitiligo. Stable vitiligo means that the areas affected by loss of pigment have been unchanged for at least the last 12 months. The study will evaluate the effect of using RECELL for repigmentation.

Qualifications:

• Male and Females, 18 years or older
• Diagnosed with Focal, segmental or generalized (i.e., nonsegmental) vitiligo photographically documented as stable (No new lesions within the previous 12 months)

Duration: Approx. 52 weeks

Location: Hackensack, NJ

Compensation: If all visits kept, up to $1350 will be paid to patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Atopic dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.

Qualifications:

• Male and Females, ages 18 to 55 years of age
• Have moderate to severe atopic dermatitis for at least 1 year
• Failure to improve with topical prescriptions

Duration: 32 weeks/ visiting doctors office 7 to 11 times

Location: Hackensack, NJ

Compensation: If all visits are kept, up to $450 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Bliss Max – Non-Invasive Body Contouring and Fat Reduction

Purpose: The objective of this clinical study is to evaluate the safety and efficacy of the combined treatment of electronic muscle stimulation, 1064 nm diode laser and pulsed electromagnetic field, vacuum assisted radio frequency for the non-invasive contouring and fat reduction of the abdomen and flanks. Subjects will be randomized to one of three arms as per randomization scheme.

Qualifications:

• Male and Females, 18 – 65 years old
• BMI ≤ 30 kg/m2
• No tattoos on the abdomen or flanks

Duration: Up to 21 weeks

Location: Hackensack, NJ

Compensation: $50 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Histological Evaluation of BTL-899 Device’s Effect on Fat Tissue

Purpose: This study will evaluate the safety and the performance of the BTL-899 study device for non-invasive study treatment reduction of subcutaneous fat. The changes in the fat tissue will be assessed histologically. Study treatment regimen consists of one study treatment and three follow-up visits – 8 hours, 24 hours and one week after the study treatment.

Qualifications:

• Adults 21 years of age or older
• BMI ≤ 35 kg/m2

Duration: Up to 1 month

Location: Hackensack, NJ

Compensation: Up to $500 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: L’Oreal Skinceuticals Tripeptide-R Neck Repair Cream in the Cosmetic Improvement of Photo-Aged Skin

Purpose: To evaluate the efficacy and safety of SkinCeuticals Tripeptide-R Neck Repair Cream for photoaged skin on the face and neck. Histologic improvements and immunostains evaluation from pre-treatment to 1 and 3 months after initiation of therapy.

Qualifications:

• Adults 18 years of age or older
• Subjects must be willing to discontinue any other skin care products with antioxidants, growth factors and/or hyaluronic acid.

Duration: Up to 3 months

Location: Hackensack, NJ

Compensation: Up to $120 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Acne

Purpose: To evaluate the safety and efficacy of the investigational Cutera® 1726 nm laser system (also referred to as ‘Alice’) for the treatment of mild to severe acne vulgaris. Subjects will receive three 1726 nm laser treatments at 3 week intervals. Follow-up visits will occur at approximately 10 days post each treatment (via phone) and at 4-, 12-, 26- and 52-weeks post-final treatment.

Qualifications:

• Female and male subjects, ages 16 to 60 years
• Fitzpatrick skin types I-IV with mild, moderate, or severe acne vulgaris

Duration: Approx. 18 months

Location: Hackensack, NJ

Compensation: $325

Interested in participating in our clinical research study? Please click here.

---

Study: Treatment to Lift Lax Skin

Purpose: To evaluate the safety and efficacy of Sofwave treatment to lift lax tissue in the submental and neck zones and to lift the eyebrow. This study is a two-arm study. Eligible patients will receive 2-4 face and/or neck and/or submental or “off the face” (abdomen, or arms, or thighs, or Décolleté) treatments (per PI discretion, 2-12 weeks apart) using the Sofwave System. Follow up visits will be conducted at 3 and 6 months post final treatment.

Qualifications:

• Healthy female and male subjects between the ages 35-80.
• Non-Smoker.
• Fitzpatrick skin type I-VI.
• Desire to lift lax skin in the neck and submental and/or to lift the brows.

Duration: Approx. 6-8 months

Location: Hackensack, NJ

Compensation: $160 for study visits

Interested in participating in our clinical research study? Please click here.

---

Study: Microneedling

Purpose: A clinical research study to test the effectiveness of the Collagen P.I.N. microneedling device in improving the appearance of moderate to severe non-facial scars. Subjects of will be required to complete four (4) treatment visits and one (1) follow-up visit.

Qualifications:

• Adults 22 years of age or older
• At least 1 non-facial trauma or surgical scar present for at least 6 months

Duration: Approx. 22 weeks

Location: Hackensack, NJ

Compensation: $250

Interested in participating in our clinical research study? Please click here.

---

Study: Naso-Labial Folds Volume Restoration

Purpose: To evaluate the effects of RENUVA® HD Treatment on human skin quality and nasolabial fold volume restoration. Subject with moderate deep wrinkles to very deep wrinkles of the nasolabial folds will receive 1 treatment using Renuva on the right and left side of the face and the right infra auricular area (behind/below their ear). Subject will undergo 5 biopsy procedures of the right treated infra auricular area: pre-treatment, day 30, day 60, day 90, and day 180 after treatment to evaluate if Renuva induces Collagen and Elastin production.

Qualifications:

• Adults aged 30 – 65
• Healthy female or male volunteers with moderate deep wrinkles to very deep wrinkles of the nasolabial folds.

Duration: Approx. 6 months

Location: Hackensack, NJ

Compensation: $375

Interested in participating in our clinical research study? Please click here.